Risk factors of endometrial cancer in patients with endometrial hyperplasia: implication for clinical treatments

[1] Vetter MH(2020)Preoperative predictors of endometrial cancer at time of hysterectomy for endometrial intraepithelial neoplasia or complex atypical hyperplasia Am J Obstet Gynecol 222 60.e61-60.e67

[2] Smith B(2020)Concurrent and future risk of endometrial cancer in women with endometrial hyperplasia: a systematic review and meta-analysis PLoS ONE 15 e0232231-2078

[3] Benedict J(2021)Pregnancy outcomes and risk of endometrial cancer: a pooled analysis of individual participant data in the Epidemiology of Endometrial Cancer Consortium Int J Cancer 148 2068-549.e513

[4] Hade EM(2020)Risk assessment of endometrial cancer and endometrial intraepithelial neoplasia in women with abnormal bleeding and implications for clinical management algorithms Am J Obstet Gynecol 223 549.e541-65.e11

[5] Bixel K(2021)Impact of uterine manipulator on oncological outcome in endometrial cancer surgery Am J Obstet Gynecol 224 65.e61-193

[6] Copeland LJ(2020)Long-term diabetes risk among endometrial cancer survivors in a population-based cohort study Gynecol Oncol 156 185-729

[7] Cohn DE(2020)Endometrial cancer, the Current International Federation of Gynecology and Obstetrics Staging System, and the Role of Imaging J Comput Assist Tomogr 44 714-130

[8] Fowler JM(2020)Factors associated with endometrial pathology during tamoxifen therapy in women with breast cancer: a retrospective analysis of 821 biopsies Breast Cancer Res Treat 179 125-857

[9] O'Malley D(2020)Metformin plus megestrol acetate compared with megestrol acetate alone as fertility-sparing treatment in patients with atypical endometrial hyperplasia and well-differentiated endometrial cancer: a randomised controlled trial BJOG 127 848-733

[10] Salani R(2020)Prospective cohort study of metabolic syndrome and endometrial cancer survival Gynecol Oncol 158 727-554

[1] Vetter MH(2020)Preoperative predictors of endometrial cancer at time of hysterectomy for endometrial intraepithelial neoplasia or complex atypical hyperplasia Am J Obstet Gynecol 222 60.e61-60.e67

[2] Smith B(2020)Concurrent and future risk of endometrial cancer in women with endometrial hyperplasia: a systematic review and meta-analysis PLoS ONE 15 e0232231-2078

[3] Benedict J(2021)Pregnancy outcomes and risk of endometrial cancer: a pooled analysis of individual participant data in the Epidemiology of Endometrial Cancer Consortium Int J Cancer 148 2068-549.e513

[4] Hade EM(2020)Risk assessment of endometrial cancer and endometrial intraepithelial neoplasia in women with abnormal bleeding and implications for clinical management algorithms Am J Obstet Gynecol 223 549.e541-65.e11

[5] Bixel K(2021)Impact of uterine manipulator on oncological outcome in endometrial cancer surgery Am J Obstet Gynecol 224 65.e61-193

[6] Copeland LJ(2020)Long-term diabetes risk among endometrial cancer survivors in a population-based cohort study Gynecol Oncol 156 185-729

[7] Cohn DE(2020)Endometrial cancer, the Current International Federation of Gynecology and Obstetrics Staging System, and the Role of Imaging J Comput Assist Tomogr 44 714-130

[8] Fowler JM(2020)Factors associated with endometrial pathology during tamoxifen therapy in women with breast cancer: a retrospective analysis of 821 biopsies Breast Cancer Res Treat 179 125-857

[9] O'Malley D(2020)Metformin plus megestrol acetate compared with megestrol acetate alone as fertility-sparing treatment in patients with atypical endometrial hyperplasia and well-differentiated endometrial cancer: a randomised controlled trial BJOG 127 848-733

[10] Salani R(2020)Prospective cohort study of metabolic syndrome and endometrial cancer survival Gynecol Oncol 158 727-554